Form 4: Arvinas Director John Young Receives Significant Equity Grants

Arvinas, Inc. Director John D. Young was granted 16,025 restricted stock units and 23,105 stock options, aligning his interests with shareholders.

Summary

• John D. Young, a Director of Arvinas, Inc. (ARVN), reported the acquisition of equity securities on June 25, 2025.
• He was granted 16,025 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock for no consideration.
• These RSUs will vest in full on the earlier of June 25, 2026, or the first board meeting after the next annual meeting of stockholders, subject to his continued service.
• Additionally, Mr. Young received an option award to buy 23,105 shares of common stock with an exercise price of $7.8 per share.
• This stock option award also vests in full on the earlier of June 25, 2026, or the first board meeting after the next annual meeting of stockholders, subject to his continued service.
• The stock options have an expiration date of June 24, 2035.
• Following these transactions, Mr. Young beneficially owns 26,045 shares of common stock directly and 23,105 derivative securities (stock options) directly.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the equity grants align the director's interests with shareholders, which is generally viewed favorably. However, it's a routine compensation event, not indicative of significant new company performance.

Positives

• The equity grants to Director John D. Young align his financial interests directly with the long-term performance and shareholder value of Arvinas, Inc.
• The vesting schedule, tied to continued service, incentivizes the director's ongoing commitment and contribution to the company.

Future Outlook

The document indicates that the granted Restricted Stock Units and stock options will vest in full on the earlier of June 25, 2026, or the first meeting of the board of directors held after the next annual meeting of stockholders, contingent upon the reporting person's continued service with Arvinas, Inc.

Industry Context

The granting of equity awards, such as Restricted Stock Units and stock options, to directors is a standard practice across various industries, including biotechnology and pharmaceuticals, to attract, retain, and incentivize key personnel by aligning their interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The equity grants align the director's incentives with shareholder interests, potentially leading to better long-term decision-making.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• Continued service of John D. Young with Arvinas, Inc. to meet vesting conditions.
• Vesting of 16,025 Restricted Stock Units on or after June 25, 2026.
• Vesting of 23,105 stock options on or after June 25, 2026.

Key Dates

Keywords

Arvinas, ARVN, SEC Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, Stock Options, Director Compensation, Beneficial Ownership